Wyndly is a seed startup based in United States. 2 investors tracked.
Based in the United States, Wyndly is a startup. Its most recent tracked round is Seed. Brouky records 3 investors associated with the company.
Wyndly is a telehealth company providing personalized allergy treatment plans, including at-home testing and sublingual immunotherapy, to help patients achieve long-term relief from allergies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.